• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣置换术后新发传导阻滞的预测因素:新一代自膨式瓣膜(VitaFlow Liberty)治疗单纯原发性主动脉瓣反流的回顾性队列研究。

Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty): a retrospective cohort study.

机构信息

Department of Cardiology, The First Affiliated Hospital (Yijishan Hospital) of Wannan Medical College, No. 2, Zheshan West Road, Jinghu District, Wuhu City, Anhui Province, China.

Department of Ultrasound Medicine, The First Affiliated Hospital (Yijishan Hospital) of Wannan Medical College, Wuhu, Anhui, China.

出版信息

BMC Cardiovasc Disord. 2024 Jan 28;24(1):77. doi: 10.1186/s12872-024-03735-z.

DOI:10.1186/s12872-024-03735-z
PMID:38281925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10822180/
Abstract

BACKGROUND

New-generation self-expanding valves can improve the success rate of transcatheter aortic valve replacement (TAVR) for severe pure native aortic regurgitation (PNAR). However, predictors of new-onset conduction block post-TAVR using new-generation self-expanding valves in patients with PNAR remain to be established. Therefore, this study aimed to identify predictors of new-onset conduction block post-TAVR using new-generation self-expanding valves (VitaFlow Liberty™) in patients with PNAR.

METHODS

In this retrospective cohort study, patients were categorized into pacemaker and non-pacemaker groups based on their need for new postoperative permanent pacemaker implantation (PPI). Based on the postoperative presence of either new-onset complete left bundle branch block (cLBBB) or high-grade atrioventricular block (AVB), patients were further classified into conduction disorder and non-conduction disorder groups. Laboratory, echocardiographic, computed tomography, preoperative and postoperative electrocardiography, and procedural and clinical data were collected immediately after TAVR and during hospitalization and compared between the groups. Multivariate logistic regression analysis was performed incorporating the significant variables from the univariate analyses.

RESULTS

This study examined 68 consecutive patients with severe PNAR who underwent TAVR. In 20 patients, a permanent pacemaker was fitted postoperatively. Multivariate logistic regression analysis revealed an association between the need for postoperative PPI and preoperative complete right bundle branch block (cRBBB) or first-degree AVB, as well as a non-tubular left ventricular outflow tract (LVOT). In addition, valve implantation depth and angle of aortic root were independent predictors of new-onset cLBBB or high-grade AVB developing post-TAVR. The predictive value of valve implantation depth and angle of aortic root was further supported by receiver operating characteristic curve analysis results.

CONCLUSIONS

In patients with PNAR undergoing TAVR using self-expanding valves, preoperative cRBBB or first-degree AVB and a non-tubular LVOT were indicators of a higher likelihood of PPI requirement. Moreover, deeper valve implantation depth and greater angle of aortic root may be independent risk factors for new-onset cLBBB or high-grade AVB post-TAVR. Valve implantation depth and angle of aortic root values may be used to predict the possibility of new cLBBB or high-grade AVB post-TAVR.

摘要

背景

新一代自膨式瓣膜可提高严重原发性主动脉瓣反流(PNAR)患者经导管主动脉瓣置换术(TAVR)的成功率。然而,对于使用新一代自膨式瓣膜(VitaFlow Liberty™)的 PNAR 患者 TAVR 后新发传导阻滞的预测因素仍有待确定。因此,本研究旨在确定使用新一代自膨式瓣膜(VitaFlow Liberty™)的 PNAR 患者 TAVR 后新发传导阻滞的预测因素。

方法

在这项回顾性队列研究中,根据术后是否需要新植入永久性起搏器(PPI),将患者分为起搏器组和非起搏器组。根据术后新发完全左束支传导阻滞(cLBBB)或高度房室传导阻滞(AVB)的存在,将患者进一步分为传导障碍组和非传导障碍组。收集 TAVR 后即刻及住院期间的实验室、超声心动图、计算机断层扫描、术前和术后心电图以及手术和临床资料,并进行组间比较。多变量逻辑回归分析纳入单变量分析中有意义的变量。

结果

本研究纳入了 68 例严重 PNAR 行 TAVR 的连续患者。在 20 例患者中,术后需要植入永久性起搏器。多变量逻辑回归分析显示,术后需要 PPI 与术前完全右束支传导阻滞(cRBBB)或一度房室传导阻滞以及非管状左心室流出道(LVOT)相关。此外,瓣膜植入深度和主动脉根部角度是 TAVR 后新发 cLBBB 或高度 AVB 的独立预测因素。瓣膜植入深度和主动脉根部角度的预测价值也得到了受试者工作特征曲线分析结果的支持。

结论

在使用自膨式瓣膜行 TAVR 的 PNAR 患者中,术前 cRBBB 或一度 AVB 和非管状 LVOT 是需要 PPI 的更高可能性的指标。此外,更深的瓣膜植入深度和更大的主动脉根部角度可能是 TAVR 后新发 cLBBB 或高度 AVB 的独立危险因素。瓣膜植入深度和主动脉根部角度值可用于预测 TAVR 后新发 cLBBB 或高度 AVB 的可能性。

相似文献

1
Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty): a retrospective cohort study.经导管主动脉瓣置换术后新发传导阻滞的预测因素:新一代自膨式瓣膜(VitaFlow Liberty)治疗单纯原发性主动脉瓣反流的回顾性队列研究。
BMC Cardiovasc Disord. 2024 Jan 28;24(1):77. doi: 10.1186/s12872-024-03735-z.
2
Impact of New-Onset Right Bundle-Branch Block After Transcatheter Aortic Valve Replacement on Permanent Pacemaker Implantation.经导管主动脉瓣置换术后新发右束支传导阻滞对永久性起搏器植入的影响。
J Am Heart Assoc. 2024 May 7;13(9):e032777. doi: 10.1161/JAHA.123.032777. Epub 2024 Apr 19.
3
Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.经导管主动脉瓣置换术使用可重定位 LOTUS 装置后的传导异常和永久性起搏器植入:英国经验。
JACC Cardiovasc Interv. 2017 Jun 26;10(12):1247-1253. doi: 10.1016/j.jcin.2017.03.044.
4
Long-Term Ventricular Pacing Dependency and Pacemaker Implantation Predictors after Transcatheter Aortic Valve Replacement - A 1-Year Follow-Up.经导管主动脉瓣置换术后长期心室起搏依赖和起搏器植入预测因素 - 1 年随访。
Arq Bras Cardiol. 2022 Oct;119(4):522-530. doi: 10.36660/abc.20210613.
5
Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.经导管主动脉瓣置换术治疗主动脉瓣狭窄后左心室流出道面积与主动脉瓣环面积的比值与完全性房室传导阻滞。
Int J Cardiol. 2024 Feb 15;397:131608. doi: 10.1016/j.ijcard.2023.131608. Epub 2023 Nov 27.
6
Utility of 30-Day Continuous Ambulatory Monitoring to Identify Patients With Delayed Occurrence of Atrioventricular Block After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后 30 天连续动态监测对诊断房室传导阻滞迟发的作用。
Circ Cardiovasc Interv. 2019 Dec;12(12):e007635. doi: 10.1161/CIRCINTERVENTIONS.118.007635. Epub 2019 Dec 13.
7
Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement.经导管主动脉瓣置换术后心肌细胞外体积分数升高与传导通路缺陷的发展有关。
Catheter Cardiovasc Interv. 2024 Nov;104(5):1119-1128. doi: 10.1002/ccd.31136. Epub 2024 Jul 2.
8
Association between implantation depth assessed by computed tomography and new-onset conduction disturbances after transcatheter aortic valve implantation.经计算机断层扫描评估的植入深度与经导管主动脉瓣植入术后新发传导障碍的关系。
J Cardiovasc Comput Tomogr. 2017 Sep-Oct;11(5):332-337. doi: 10.1016/j.jcct.2017.08.003. Epub 2017 Aug 18.
9
Predictors of Early and Late Atrioventricular Block Requiring Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Single-Center Experience.经导管主动脉瓣置换术后需要永久性心脏起搏器植入的早期和晚期房室传导阻滞的预测因素:单中心经验。
Cardiovasc Revasc Med. 2022 Sep;42:67-71. doi: 10.1016/j.carrev.2022.02.002. Epub 2022 Feb 9.
10
Impact of tapered-shape left ventricular outflow tract on pacemaker rate after transcatheter aortic valve replacement.经导管主动脉瓣置换术后左心室流出道锥形对起搏器频率的影响。
Heart Vessels. 2022 Jun;37(6):1055-1065. doi: 10.1007/s00380-021-01999-5. Epub 2022 Jan 7.

引用本文的文献

1
Predictors of pacemaker implantation in aortic regurgitation patients treated with a dedicated transcatheter heart valve.接受专用经导管心脏瓣膜治疗的主动脉瓣反流患者植入起搏器的预测因素。
EuroIntervention. 2025 Jun 16;21(12):e681-e691. doi: 10.4244/EIJ-D-24-01117.
2
Outcomes of Permanent Pacemaker Implantation in Patients with Pure Aortic Regurgitation after TAVI.经导管主动脉瓣置入术后单纯主动脉瓣反流患者永久性起搏器植入的结局
Rev Cardiovasc Med. 2025 May 22;26(5):26543. doi: 10.31083/RCM26543. eCollection 2025 May.

本文引用的文献

1
Predictors of permanent pacemaker implantation in aortic valve diseases after TAVI with vitaFlow liberty system.使用vitaFlow liberty系统进行经导管主动脉瓣置换术后主动脉瓣疾病患者永久性起搏器植入的预测因素
Front Cardiovasc Med. 2023 Sep 29;10:1277528. doi: 10.3389/fcvm.2023.1277528. eCollection 2023.
2
Evaluation of the safety and efficacy of a novel Anatomical classification and dUal anchoRing theory to Optimize the tavR strategy for pure severe Aortic regurgitation (AURORA): a prospective cohort study.新型解剖学分类和双重锚定理论优化单纯重度主动脉瓣反流(AURORA)塔夫尔策略的安全性和有效性评价:一项前瞻性队列研究。
BMC Cardiovasc Disord. 2022 Oct 15;22(1):445. doi: 10.1186/s12872-022-02883-4.
3
Comparison of cusp-overlap projection and standard three-cusp coplanar view during self-expanding transcatheter aortic valve replacement: A systematic review and meta-analysis.
自膨式经导管主动脉瓣置换术中瓣叶重叠投影与标准三尖瓣共面视图的比较:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2022 Aug 17;9:927642. doi: 10.3389/fcvm.2022.927642. eCollection 2022.
4
Outcomes in patients with electrocardiographic left ventricular dyssynchrony following transcatheter aortic valve replacement.经导管主动脉瓣置换术后心电图左心室不同步患者的结局
Heart Rhythm. 2023 Jan;20(1):22-28. doi: 10.1016/j.hrthm.2022.08.001. Epub 2022 Aug 7.
5
Mid- to Long-Term Clinical and Echocardiographic Effects of Post-procedural Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.经导管主动脉瓣置换术后永久性起搏器植入的中长期临床及超声心动图效果:一项系统评价与荟萃分析
Front Cardiovasc Med. 2022 Jun 28;9:911234. doi: 10.3389/fcvm.2022.911234. eCollection 2022.
6
A study on correlation between preprocedural CT indexes and procedural success rate of transfemoral transcatheter aortic valve replacement with different self-expanding valves (VitaFlow or VenusA-Valve) in patients with pure native aortic regurgitation.一项关于单纯原发性主动脉瓣反流患者经股动脉行不同自膨式瓣膜(VitaFlow或VenusA-Valve)经导管主动脉瓣置换术前CT指标与手术成功率之间相关性的研究。
Ann Transl Med. 2022 Jun;10(11):643. doi: 10.21037/atm-22-2588.
7
Comparative Quantitative Aortographic Assessment of Regurgitation in Patients Treated With VitaFlow Transcatheter Heart Valve vs. Other Self-Expanding Systems.VitaFlow经导管心脏瓣膜与其他自膨胀系统治疗患者反流的比较性定量主动脉造影评估
Front Cardiovasc Med. 2022 Jan 25;8:747174. doi: 10.3389/fcvm.2021.747174. eCollection 2021.
8
Cusp-Overlapping Projections in TAVR: Where the Left Meets the Right.经导管主动脉瓣置换术中的瓣叶重叠投影:左右交汇之处
JACC Cardiovasc Interv. 2022 Jan 24;15(2):162-164. doi: 10.1016/j.jcin.2021.12.006.
9
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
10
Current status and etiology of valvular heart disease in China: a population-based survey.中国瓣膜性心脏病的现状和病因:一项基于人群的调查。
BMC Cardiovasc Disord. 2021 Jul 13;21(1):339. doi: 10.1186/s12872-021-02154-8.